21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Letter to the editor: results from a Web‐based survey to identify dynapenia screening tools and risk factors

      letter
      1 , 2
      Journal of Cachexia, Sarcopenia and Muscle
      John Wiley and Sons Inc.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Conflict of interest Todd M Manini and Brian C Clark declare they have no conflict of interest. There is increased focus on using muscle strength as an indicator of clinically relevant muscle weakness.1, 2 However, there is little information about how to efficiently screen patients who might have a risk of clinically significant muscle weakness. We identified potential respondents by entering combinations of the following search terms: geriatrics, sarcopenia, dynapenia, physical function, aging, muscle strength, muscle power, and/or physical disability in Medline. We presumed that the authors of these papers would be able to provide insight on screening for muscle weakness. We then located email contact information for each author. Drs Clark and Manini personally invited 212 authors to complete a brief Web‐based survey that asked questions concerning screening for risk factors related to age‐related muscle weakness that we referred to as dynapenia.3 The respondents were asked to provide answers to an anonymous Web‐based poll that remains active (http://www.dynapenia.blogspot.com/).4 The poll asked the following questions: (i) ‘Is grip strength an appropriate screening tool?’, (ii) ‘Is a knee extension strength test appropriate for defining dynapenia?’, (iii) ‘Should age be considered an absolute indication for screening for dynapenia?’, and (iv) ‘Please pick the 5 most predictive risk factors for dynapenia’. Twenty‐four people responded to the survey, and there were 127 responses for risk factors of dynapenia. We found that 50% (n = 12) of the respondents considered grip strength an appropriate screening tool, whereas 16% considered it unnecessary, and 16% considered it to be a poor predictive factor. Similarly, 57% of the respondents considered knee extension strength appropriate to define dynapenia, while 28% instead recommended walking speed, 9% suggested multi‐joint testing, and 4% recommended muscle power, respectively, as better tests to define dynapenia. Moreover, 54% of the respondents did not consider age as an absolute indicator of screening for dynapenia, while 18% believed it to be for age >55 years old, 13% considered that it should be for people aged >65 years old, and 9% considered that it should be for people aged >75 years old. There were 127 responses to the top five most predictive risk factors for dynapenia (Figure 1). In order of highest percentage positive response, the respondents chose low physical activity, report of weakness, age >80 years, unintentional weight loss, and high inflammatory load as the top five most predictive risk factors (n = 127). Sequential Chi‐square tests of proportions identified that the responses were clustered into four major groups that are identified by colour in Figure 1. Low physical activity, a report of muscle weakness, and being >80 years of age clustered into the most prevalent responses. Unintentional weight loss, inflammation, fatigue, osteoarthritis, obesity, and hypoxic disease formed a second cluster. Vitamin D deficiency, osteoporosis, active cancer, and other conditions formed a third cluster. Selections for anaemia, cardiovascular disease, cancer in last 3 years, alcoholism, smoking, and thyroid conditions were the least frequently chosen. Figure 1 Proportion responding to the five most predictive risk factors for dynapenia. This Web‐based survey provides information about the opinions of a small, but select group of respondents publishing in the field of geriatrics, gerontology, ageing, muscle, and physical function. Recently, grip strength—because of ease of use, predictive capability, and robust use across many studies—has been identified as a potential screening tool to label older adults with clinically significant muscle weakness.5 Approximately half of the respondents felt that grip strength was an appropriate tool for screening. These opinions might be different today, considering that the survey was completed prior to latest knowledge provided by the FNIH Sarcopenia Project.6 We might expect this rate to increase as more knowledge about the screening capabilities of measuring grip strength is put forth in the literature. While this Web survey asked the opinions of the respondents who publish in the field, the results cautioned to be directly used without large representation from the clinical community. We acknowledge that because this survey was available to the public, individuals without specific expertise on sarcopenia/dynapenia could have provided responses. Identifying older adults at risk of physical disability using various sarcopenia and clinically significant weakness definitions is an emerging area of research. As such, these results may provide a guide for practitioners to understand the opinions of respondents who are likely to be experts in the field. The aim is to help initiate a brief set of questions that can be efficiently administered by practitioners. Conclusions Grip strength and knee extension strength were considered appropriate tools to screen dynapenia by a majority of respondents. The respondents chose low physical activity, reported weakness, and age >80 years as being the most important risk factors for dynapenia. The results are expected to help develop a simple question‐based screening approach to gauge a patient's risk of dynapenia. Acknowledgements The authors have complied with the guidelines of ethical authorship and publishing as stated in the Journal of Cachexia, Sarcopenia and Muscle: update 2015).7 This work was supported by the following grants from the National Institutes of Health's National Institute on Aging: R01 AG042525, R01 AG044424, and the University of Florida, Claude D. Pepper Center (P30 AG028740). This work was considered non‐human research, and therefore, was exempt from ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This work was sponsored by the National Institutes of Health. The sponsors had no role in the concept, design, methods, and analysis or preparation of paper.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Grip Strength Cutpoints for the Identification of Clinically Relevant Weakness

          Background. Weakness is common and contributes to disability, but no consensus exists regarding a strength cutpoint to identify persons at high risk. This analysis, conducted as part of the Foundation for the National Institutes of Health Sarcopenia Project, sought to identify cutpoints that distinguish weakness associated with mobility impairment, defined as gait speed less than 0.8 m/s. Methods. In pooled cross-sectional data (9,897 men and 10,950 women), Classification and Regression Tree analysis was used to derive cutpoints for grip strength associated with mobility impairment. Results. In men, a grip strength of 26–32 kg was classified as “intermediate” and less than 26 kg as “weak”; 11% of men were intermediate and 5% were weak. Compared with men with normal strength, odds ratios for mobility impairment were 3.63 (95% CI: 3.01–4.38) and 7.62 (95% CI 6.13–9.49), respectively. In women, a grip strength of 16–20 kg was classified as “intermediate” and less than 16 kg as “weak”; 25% of women were intermediate and 18% were weak. Compared with women with normal strength, odds ratios for mobility impairment were 2.44 (95% CI 2.20–2.71) and 4.42 (95% CI 3.94–4.97), respectively. Weakness based on these cutpoints was associated with mobility impairment across subgroups based on age, body mass index, height, and disease status. Notably, in women, grip strength divided by body mass index provided better fit relative to grip strength alone, but fit was not sufficiently improved to merit different measures by gender and use of a more complex measure. Conclusions. Cutpoints for weakness derived from this large, diverse sample of older adults may be useful to identify populations who may benefit from interventions to improve muscle strength and function.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Criteria for Clinically Relevant Weakness and Low Lean Mass and Their Longitudinal Association With Incident Mobility Impairment and Mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project

            Background. This analysis sought to determine the associations of the Foundation for the National Institutes of Health Sarcopenia Project criteria for weakness and low lean mass with likelihood for mobility impairment (gait speed ≤ 0.8 m/s) and mortality. Providing validity for these criteria is essential for research and clinical evaluation. Methods. Among 4,411 men and 1,869 women pooled from 6 cohort studies, 3-year likelihood for incident mobility impairment and mortality over 10 years were determined for individuals with weakness, low lean mass, and for those having both. Weakness was defined as low grip strength (<26kg men and <16kg women) and low grip strength-to-body mass index (BMI; kg/m2) ratio (<1.00 men and <0.56 women). Low lean mass (dual-energy x-ray absorptiometry) was categorized as low appendicular lean mass (ALM; <19.75kg men and <15.02kg women) and low ALM-to-BMI ratio (<0.789 men and <0.512 women). Results. Low grip strength (men: odds ratio [OR] = 2.31, 95% confidence interval [CI] = 1.34–3.99; women: OR = 1.99, 95% CI 1.23–3.21), low grip strength-to-BMI ratio (men: OR = 3.28, 95% CI 1.92–5.59; women: OR = 2.54, 95% CI 1.10–5.83) and low ALM-to-BMI ratio (men: OR = 1.58, 95% CI 1.12–2.25; women: OR = 1.81, 95% CI 1.14–2.87), but not low ALM, were associated with increased likelihood for incident mobility impairment. Weakness increased likelihood of mobility impairment regardless of low lean mass. Mortality risk patterns were inconsistent. Conclusions. These findings support our cut-points for low grip strength and low ALM-to-BMI ratio as candidate criteria for clinically relevant weakness and low lean mass. Further validation in other populations and for alternate relevant outcomes is needed.
              Bookmark

              Author and article information

              Contributors
              tmanini@ufl.edu
              Journal
              J Cachexia Sarcopenia Muscle
              J Cachexia Sarcopenia Muscle
              10.1007/13539.2190-6009
              JCSM
              Journal of Cachexia, Sarcopenia and Muscle
              John Wiley and Sons Inc. (Hoboken )
              2190-5991
              2190-6009
              23 August 2016
              September 2016
              : 7
              : 4 ( doiID: 10.1002/jcsm.v7.4 )
              : 499-500
              Affiliations
              [ 1 ] Institute on Aging, Department of Aging and Geriatric ResearchUniversity of Florida Gainesville FLUSA
              [ 2 ] Ohio Musculoskeletal and Neurological Institute (OMNI), Department of Biomedical SciencesOhio University Athens OHUSA
              Author notes
              [†]

              Study concept and design, data analysis, interpretation of data, and preparation of manuscript.

              Article
              JCSM12128 JCSM-D-16-00107
              10.1002/jcsm.12128
              5011825
              27625921
              04ac099c-0aac-45c1-a2c6-d7222380ff38
              © 2016 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society of Sarcopenia, Cachexia and Wasting Disorders

              This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

              History
              : 04 May 2016
              : 16 May 2016
              Page count
              Figures: 1, Tables: 0, Pages: 2, Words: 1132
              Funding
              Funded by: NIA
              Award ID: P30 AG028740
              Award ID: R01 AG042525
              Award ID: R01 AG044424
              Categories
              Letter to the Editor
              Letters to the Editor
              Custom metadata
              2.0
              jcsm12128
              jcsm12128-hdr-0001
              September 2016
              Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:06.09.2016

              Orthopedics
              Orthopedics

              Comments

              Comment on this article